Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes.
Division of Hospital Medicine, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
P K
PK
Bhamidipati
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
J F
JF
DiPersio
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
K
K
Stokerl-Goldstein
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
A
A
Rashidi
Department of Biostatistics, Washington University School of Medicine, Saint Louis, MO, USA.
F
F
Gao
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
G L
GL
Uy
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
P
P
Westervelt
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
R
R
Vij
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
M A
MA
Schroeder
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
C N
CN
Abboud
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
J W
JW
Keller
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
T A
TA
Fehniger
Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
R
R
Romee
D000328:Adult; D000368:Aged; D064591:Allografts; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D019337:Hematologic Neoplasms / Q000401:mortality / Q000628:therapy; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D008212:Lymphocyte Depletion; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D015996:Survival Rate; D013997:Time Factors; D019172:Transplantation Conditioning
D016179:Granulocyte Colony-Stimulating Factor